CONMED Corporation (CNMD) is a publicly traded Healthcare sector company. As of October 28, 2026, CNMD trades at $45.63 with a market cap of $1.41B and a P/E ratio of 25.05. CNMD moved -2.87% today. Year to date, CNMD is +12.93%; over the trailing twelve months it is -3.30%. Its 52-week range spans $31.44 to $64.87. Analyst consensus is neutral with an average price target of $45.25. Rallies surfaces CNMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CONMED raises 2026 adjusted EPS guidance as international sales grow: CONMED raised its 2026 adjusted diluted EPS guidance to $4.54–$4.61 and expects net sales of $1.36 billion–$1.366 billion. Q3 sales fell 0.7% to $335.56 million, while adjusted EPS of $1.04 exceeded the $1.003 analyst estimate.
| Metric | Value |
|---|---|
| Price | $45.63 |
| Market Cap | $1.41B |
| P/E Ratio | 25.05 |
| EPS | $1.85 |
| Dividend Yield | 0.20% |
| 52-Week High | $64.87 |
| 52-Week Low | $31.44 |
| Volume | 449.64K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.37B |
| Net Income | $56.50M |
| Gross Margin | 55.79% |
6 analysts cover CNMD: 0 strong buy, 0 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $45.25.